Hillrom and Welch Allyn are a part of Baxter.
23px-Flag_baxterUS.svg.png  United States
text.skipToContent text.skipToNavigation
  1. Baxter Catalog
  2. Pharmaceuticals
  3. Premixed Medications
  4. DOBUTamine Hydrochloride in 5% Dextrose Injection, 1000mg/250 mL in VIAFLEX Plastic Container. Liquid Premix.
Due to missing information on your Hillrom Direct account, you are not able to add items to the cart or continue with the checkout process. Please contact our customer support team for further assistance by clicking on "contact us".
MP_logo
DOBUTamine Hydrochloride in 5% Dextrose Injection, 1000mg/250 mL in VIAFLEX Plastic Container. Liquid Premix.
No Image Available
Item Number: 2B0793
GTIN:  0303381077020
GTIN-CS:  50303381077025
DOBUTamine Hydrochloride in 5% Dextrose Injection, 1000 mg/250 mL (4000 mcg/mL) in VIAFLEX Plastic Container. Liquid Premix. NDC 0338-1077-02
print-icon Print email-icon Email
Email PDF ✕
Specifications

Product Characteristics

Minimum Storage Temperature 0.0 °C
Maximum Storage Temperature 0.0 °C
Volume 250.0 ml
Shelf Life from Manufacture 15 months
Concentration 4000 mcg/mL
Container Type VIAFLEX
Containes Preservative No
Diluent Dextrose
Dosage Form Liquid
Drug Class Cardio- Vascular
Rx Only Yes
Storage Recommendations Store at room temperature 25°C (77°F), brief exposure up to 40° C (104° F) does not adversely affect the product.
Strength 1000 mg/250 mL

Carton

Units per Case 18.0
Carton Weight 14.0 lb.
Carton Length 20.0 in.
Carton Width 13.5 in.
Carton Height 6.5 in.
Carton Volume 1.02 fc

Reimbursement Information

HCPCS Code HCPCS Description
J1250 INJECTION, DOBUTAMINE HYDROCHLORIDE, PER 250 MG
A4216 STERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML
Medication Delivery Reimbursement Hotline 888-338-0001

Information Source : CMS

Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
Ordering Information
Item Number 2B0793
Sales Unit case
GTIN 0303381077020
GTIN-CS 50303381077025
National Drug Code 00338107702
Documents

Documentation

Link

Website Links

     203052r1